Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aerie Pharmaceuticals Inc (NASDAQ:AERI)

44.05
Delayed Data
As of Apr 28
 -0.45 / -1.01%
Today’s Change
12.56
Today|||52-Week Range
51.85
+16.38%
Year-to-Date

Today’s Trading

Previous close44.50
Today’s open44.55
Day’s range43.90 - 44.90
Volume213,039
Average volume (3 months)380,270
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-18.06%
Earnings growth (this year)+3.55%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book13.99

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.03-0.34%
PBYIPuma Biotechnology I...+0.65+1.63%
DERMDermira Inc+0.22+0.65%
EGRXEagle Pharmaceutical...+0.07+0.08%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$0.00
Annual profit (last year)-$99.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Vicente J. Anido
President &
Chief Operating Officer
Thomas A. Mitro
Corporate headquarters
Irvine, California

Forecasts